Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
25,296,136
-
Total 13F shares
-
38,938
-
Share change
-
+38,938
-
Total reported value
-
$90,552
-
Price per share
-
$2.33
-
Number of holders
-
9
-
Value change
-
+$90,552
-
Number of buys
-
9
Institutional Holders of Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) as of Q4 2022
As of 31 Dec 2022,
Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,938 shares.
The largest 9 holders included
VANGUARD GROUP INC, BlackRock Inc., UBS Group AG, EMFO, LLC, Tower Research Capital LLC (TRC), MORGAN STANLEY, WELLS FARGO & COMPANY/MN, FIRST MANHATTAN CO, and BANK OF AMERICA CORP /DE/.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.